EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieStudienprotokollOpen Access · CC BY-NC-ND 4.0

Reopening schools safely and educating youth (ROSSEY) study: Protocol for a community-based, cluster randomized controlled trial

Magaly Ramirez, Parth D Shah, Helen Y Chu, Lorenzo Garza, Sandra Linde, Michelle M Garrison, Chuan Zhou, Sonia Bishop, Genoveva Ibarra, Linda K Ko

Contemporary Clinical Trials · 2024

DOI: 10.1016/j.cct.2024.107480 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Contemporary Clinical Trials, 2024. Verfasst von Magaly Ramirez und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Systems and Population Health, University of Washington School of Public Health, Seattle, WA, United States of America. Electron…. Hauptthemen laut MEDLINE: COVID-19, COVID-19 Testing. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NICHD NIH HHS, NCATS NIH HHS, Institute of Translational Health Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: ROSSEY is a community-academic partnership aiming to develop and test a COVID-19 risk communication intervention for elementary school students and families in Yakima County, Washington. We describe the ROSSEY study protocol that will be implemented in the Yakima School District. METHODS: Aim 1 is to identify the community's social, ethical, and behavioral needs and resources for students to return to school and maintain onsite learning. We will conduct semi-structured interviews with students and school employees and focus groups with parents.

Aim

2 is to evaluate the effectiveness of risk communication on students' school attendance. We will conduct a cluster randomized control trial. We will enroll 14 Yakima School District elementary schools with 900 student participants and randomize the schools into the COVID-19 risk communication intervention or control group.

Aim

3 will assess implementation of the risk communication intervention and schools' COVID-19 mitigation strategies. We will use the RE-AIM framework to guide this work, which will entail conducting semi-structured interviews with students and school employees and focus groups with parents. DISCUSSION: Implementation of science-based risk communication can educate the community on the benefits and safety of COVID-19 testing and vaccination. Risk communication may also inform families about the role of COVID-19 testing and vaccines as part of mitigation strategies to allow for safe in-person learning. Schools have extraordinary influence to promote children's health through policy and practice change. Study findings will provide evidence to facilitate policy decisions and best practices at schools that facilitate adoption of COVID-19 risk communication. TRIAL REGISTRATION: ClinicalTrials.govNCT04859699. Registered on April 26, 2021.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19COVID-19 TestingChildHumansLearningRandomized Controlled Trials as TopicSchool Health ServicesSchoolsStudents

Stichwörter der Autor:innen

COVID-19 testingChild healthCommunicationHispanic or LatinoSchool health services

Autor:innen und Institutionen

  • Department of Health Systems and Population Health, University of Washington School of Public Health, Seattle, WA, United States of America. Electronic address: maggiera@uw.edu.
  • Department of Health Systems and Population Health, University of Washington School of Public Health, Seattle, WA, United States of America; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, U…
  • Department of Medicine, Allergy & Infectious Diseases, University of Washington School of Medicine, Seattle, WA, United States of America.
  • Sunnyside School District, Sunnyside, WA, United States of America.
  • Astria Health, Sunnyside, WA, United States of America.
  • Department of Public Health, Purdue University College of Health and Human Sciences, West Lafayette, IN, United States of America.

Förderung

  • NICHD NIH HHS
  • NCATS NIH HHS
  • Institute of Translational Health Sciences
  • National Institute of Child Health and Human Development
  • National Institutes of Health

Zitieren

APA

Ramirez, M., Shah, P. D., Chu, H. Y., Garza, L., Linde, S., Garrison, M. M., Zhou, C., Bishop, S., Ibarra, G., & Ko, L. K. (2024). Reopening schools safely and educating youth (ROSSEY) study: Protocol for a community-based, cluster randomized controlled trial. Contemporary Clinical Trials. https://doi.org/10.1016/j.cct.2024.107480

Vancouver

Ramirez M, Shah PD, Chu HY, Garza L, Linde S, Garrison MM, et al. Reopening schools safely and educating youth (ROSSEY) study: Protocol for a community-based, cluster randomized controlled trial. Contemporary Clinical Trials. 2024. doi:10.1016/j.cct.2024.107480

BibTeX
@article{Ramirez2024,
  author = {Ramirez, Magaly and Shah, Parth D and Chu, Helen Y and Garza, Lorenzo and Linde, Sandra and Garrison, Michelle M and Zhou, Chuan and Bishop, Sonia and Ibarra, Genoveva and Ko, Linda K},
  title = {Reopening schools safely and educating youth (ROSSEY) study: Protocol for a community-based, cluster randomized controlled trial},
  journal = {Contemporary Clinical Trials},
  year = {2024},
  doi = {10.1016/j.cct.2024.107480}
}
Kostenlos starten →